Zimmer Biomet's ROSA ONE Spine System Wins FDA Nod; Other Solutions Presented At AAOS 2019
US FDA cleared Zimmer Biomet's ROSA ONE spine application last Friday. During the recent Academy of Orthopedics Surgeons conference, Medtech Insight talked to Zimmer Biomet's general manager of Global Spine, Rebecca Whitney and Michelle Bianco, VP of Operations, to learn about the company's product pipeline and future strategy.
You may also be interested in...
Simplify’s total disc replacement complements NuVasive’s C360 line of cervical repair surgery devices, addressing a market that could eventually be worth $2.6bn.
Robotic systems took center stage at this year's annual spine society meeting in Chicago. NuVasive unveiled its new Pulse robotic spine surgery system with several differentiating features. Globus Medical showcased a new imaging platform and Interbody module.
Zimmer Biomet’s net sales were up 1.2% year-over-year in the second quarter. CEO Bryan Hanson said the ROSA Knee robotic surgery system is performing even better than expected since it launched earlier this year, and is expected to be an important revenue-driver in the future.